Category Archives: Newsroom

Premier Integrated Labs and Mindray Forge Strategic Partnership to Advance Diagnostic Innovation

Premier Integrated Labs (PIL) is proud to announce a significant milestone with the official signing of a Memorandum of Understanding (MoU) with Mindray, a global leader in medical devices and solutions. This strategic partnership marks a powerful collaboration aimed at advancing innovation in the in-vitro diagnostics (IVD) industry.

The MoU signing signifies a shared commitment between PIL and Mindray to enhance the quality, efficiency, and accessibility of diagnostic services across Malaysia. Both parties will work closely to introduce cutting-edge IVD technologies that empower healthcare professionals with faster, more accurate, and data-driven insights for better clinical decision-making.

This partnership is a reflection of PIL’s continuous efforts to stay at the forefront of diagnostic excellence and innovation. With Mindray’s strong global reputation for research, development, and state-of-the-art solutions, the collaboration is expected to strengthen local diagnostic capabilities and improve patient outcomes nationwide.

By aligning visions and expertise, this partnership not only benefits medical institutions but also contributes to the broader goal of elevating Malaysia’s healthcare standards. It underscores a mutual dedication to supporting the nation’s healthcare transformation through reliable, high-performance diagnostic systems.

Premier Integrated Labs looks forward to a meaningful collaboration and a future of shared success with Mindray, built on trust, innovation, and a unified goal of improving lives through science and technology.

 Premier Integrated Labs: Revolutionizing Preventive Healthcare with Metabolomic Testing

Premier Integrated Labs is proud to be the first in Malaysia to introduce Metabolomic Testing, a revolutionary advancement in preventive healthcare. This cutting-edge test, developed in partnership with Lifespin GmbH, harnesses the power of AI-driven analysis to assess 250+ biomarkers, providing a deep understanding of an individual’s metabolic health.

Unlike conventional tests, Metabolomic Testing detects subtle biochemical changes that may indicate early signs of heart disease, diabetes, inflammation, and other metabolic disorders. By identifying these risks before symptoms appear, individuals can take proactive steps to manage their health more effectively.

This breakthrough marks a new era in healthcare, where prevention is prioritized over treatment. With personalized, data-driven insights, patients and healthcare providers can make informed decisions for better long-term health outcomes.

At Premier Integrated Labs, we are committed to bringing innovative solutions that empower individuals to take control of their well-being. Experience the future of healthcare today because early detection saves lives.

New state-of-the-art laboratory enhances diagnostics and supports Sarawak’s medical tourism potential.

Premier Integrated Labs (PIL) has officially opened its new laboratory in Kuching, marking a significant milestone in our mission to expand high-quality diagnostic services. This facility, equipped with cutting-edge technology, enhances our ability to provide early disease detection and improved health outcomes for communities in Sarawak and beyond.

The opening ceremony was officiated by Deputy Health Minister YB Dato Lukanisman Awang Sauni, who highlighted PIL’s role in transforming Sarawak’s healthcare landscape. This expansion not only strengthens local diagnostic capabilities but also supports the state’s potential as a hub for medical tourism, attracting patients seeking reliable and accessible healthcare solutions.

With this new addition, our PIL family continues to grow, and we remain dedicated to making accurate, accessible, and efficient diagnostics a reality for more communities. We look forward to further collaborations that drive innovation and improve healthcare services across the region

New corporate office sets the stage for collaboration, growth, and a shared vision for the future.

On 15 January 2025, Premier Integrated Labs (PIL) hosted its Partner & Vendor Engagement Day at the newly opened Corporate Office, bringing together partners and vendors in a refreshed and modern environment. This event provided a valuable opportunity to foster stronger collaborations, share insights, and discuss ways to achieve shared growth with our valued partners.

The day’s activities continued with the PIL Townhall 2025, where CEO En Hareeff took the stage to share significant company updates, celebrate recent achievements, and outline the vision for the year ahead. The townhall was an inspiring session that united the team, aligning everyone with the company’s goals and reinforcing PIL’s commitment to excellence and innovation.

This event was filled with meaningful connections and a renewed sense of purpose, setting the tone for a successful year ahead. PIL is excited to continue building on these strong partnerships and drive progress together.

The Role of HPV Screening in Cervical Cancer Prevention

In collaboration with Roche, Premier Integrated Labs (PIL) hosted a successful symposium at The Vertical, Bangsar South, with over 50 attendees including GPs, hospitals, government agencies, and non-profit organizations on 8th December 2024. The event aimed to raise awareness of the critical issue of cervical cancer elimination and the importance of HPV primary screening in early detection and prevention. The symposium featured esteemed speakers such as Dr. Chew Ghee Kheng, Dr. Yogeeta A/P Gunasagran, and Dr. Khoo Su Pei, who shared their expertise on HPV screening and its significance in reducing cervical cancer mortality rates.

PIL is proud to support this effort, having processed over 60,000 HPV screening samples as part of government initiatives this year. We extend our gratitude to all participants for their dedication to improving patient care and contributing to the national effort to eliminate cervical cancer, building a future where women’s health is prioritized, and cervical cancer is no longer a threat.